ADUS
Addus Homecare Corp Health Care Services-Home Health Care Services Russell 3000
$125.54Close
$2.3BMarket cap
$88.49 – $125.5452-week range
Nov 3, 2026Next report · after the close
Highlights
Strengths
- Near its high at its 52-week high
- Earnings growing EPS +24% year on year, faster than the quarter before (+7 pts)
Cautions
- Trend not confirmed 7 of 8 conditions · RS under 70
- Results soon Nov 3, 2026, in 2 days
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Key figures
Off 12-month high
0%
1wk
up 3.1%
price change
1mo
up 13.6%
price change
12-month return
up 6%
market up 11% ·
its own down 9%
F-score
5 / 9
Mixed
Altman Z″
5.50
Low risk
P/E
24.2×
price / earnings
PEG
1.05
P/E / EPS growth
P/B
2.1×
price / book
Earnings yield
up 5.7%
EBIT / enterprise value
Cheaper than
67%
of the market · cheap
Revenue growth
up 23%
year on year
EPS growth
up 24%
latest quarter · +7 pts
Sales growth
up 8%
latest quarter · +0 pts
ROE
up 9%
return on equity
Free cash margin
up 7%
$103.8M FCF
D/E
0.11
long-term debt / equity
Net debt / EBITDA
—
Interest cover
10.2×EBIT / interest
Piotroski tests
- profitability slipped from last year
- issued more shares
- gross margin narrowed
- assets working less efficiently
- profitable on its assets
- generating cash from operations
- profits backed by cash
- reduced long-term debt
- short-term liquidity improved
Repair signals
- Long-term debt down 45% ($0.2B → $0.1B)
Trade setup
ATR%
2.2%
$2.76 a day · 2×ATR $120.01
RS
68 / 99
vs the universe
Trend
7 / 8
RS under 70
Relative volume
1.5×
vs 50-day average
Up/down volume
1.02
50 sessions
Implied move
—
no option chain · report Nov 3, 2026
Trend template · 7 of 8
- RS rank 70 or higher: fails
Screen verdict
Did not qualify for any screen.
Warning signs
- Shareholders diluted The share count rose 2.0% over the year, from 18m to 19m shares. Each existing share owns a smaller fraction of the company than it did a year ago.
Last reported
Aug 3, 2026
Results reaction
Aug 3, 2026-5% vs market2 sessions after results
Financials
- Gross 32%
- Net 7%
- Free cash 7%
- Cash
- Long-term debt
| FY2020Dec 31, 2020 | FY2021Dec 31, 2021 | FY2022Dec 31, 2022 | FY2023Dec 31, 2023 | FY2024Dec 31, 2024 | FY2025Dec 31, 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $764.8M | $864.5M | $951.1M | $1.1B | $1.2B | $1.4B |
| Gross margin | 30% | 31% | 32% | 32% | 32% | 32% |
| Operating income | $44.5M | $65.9M | $68.7M | $91.0M | $102.7M | $138.6M |
| Net income | $33.1M | $45.1M | $46.0M | $62.5M | $73.6M | $95.9M |
| Net margin | 4% | 5% | 5% | 6% | 6% | 7% |
| Earnings per share | $2.08 | $2.81 | $2.84 | $3.83 | $4.23 | $5.22 |
| Free cash flow | $102.6M | $34.8M | $96.8M | $102.8M | $110.4M | $103.8M |
| Free cash margin | 13% | 4% | 10% | 10% | 10% | 7% |
| Cash | $145.1M | $168.9M | $80.0M | $64.8M | $98.9M | — |
| Long-term debt | $193.9M | $220.9M | $131.8M | $124.1M | $218.4M | $121.0M |
| Shareholders' equity | $518.7M | $574.3M | $633.5M | $706.7M | $970.5M | $1.1B |
| Shares outstanding | 15.83m | 15.94m | 16.13m | 16.23m | 18.15m | 18.52m |
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Aug 4, 2026 | Quarterly ↗ | Jun 30, 2026 | 35d |
| May 5, 2026 | Quarterly ↗ | Mar 31, 2026 | 35d |
| Feb 24, 2026 | Annual ↗ | Dec 31, 2025 | 55d |
| Nov 4, 2025 | Quarterly ↗ | Sep 30, 2025 | 35d |
| Aug 5, 2025 | Quarterly ↗ | Jun 30, 2025 | 36d |
| May 6, 2025 | Quarterly ↗ | Mar 31, 2025 | 36d |
| Feb 25, 2025 | Annual ↗ | Dec 31, 2024 | 56d |
| Nov 5, 2024 | Quarterly ↗ | Sep 30, 2024 | 36d |
| Aug 6, 2024 | Quarterly ↗ | Jun 30, 2024 | 37d |
| May 7, 2024 | Quarterly ↗ | Mar 31, 2024 | 37d |
| Feb 27, 2024 | Annual ↗ | Dec 31, 2023 | 58d |
| Oct 31, 2023 | Quarterly ↗ | Sep 30, 2023 | 31d |
Current reports
| Filed | Disclosed |
|---|---|
| Sep 14, 2026 | Material agreement · Regulation FD ↗ |
| Aug 13, 2026 | Director or officer change · Regulation FD ↗ |
| Aug 3, 2026 | Results · Regulation FD ↗ |
| Jun 10, 2026 | Shareholder vote ↗ |
| May 4, 2026 | Results · Regulation FD ↗ |
| Feb 23, 2026 | Results · Regulation FD ↗ |
| Nov 3, 2025 | Results · Regulation FD ↗ |
| Aug 7, 2025 | Director or officer change · Regulation FD ↗ |
| Aug 4, 2025 | Results · Regulation FD ↗ |
| Jun 23, 2025 | Shareholder vote ↗ |
| May 5, 2025 | Results · Regulation FD ↗ |
| Mar 11, 2025 | Director or officer change · Regulation FD ↗ |